A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia

MLA

Paolo Bossi, et al. “A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.” Cancers, vol. 13, no. 3456, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1f9457212ff201b95cbbabb52a8e06ae&authtype=sso&custid=ns315887.

APA

Paolo Bossi, Cristiana Bergamini, M. Franceschini, Nicola Alessandro Iacovelli, Rossana Ingargiola, Salvatore Alfieri, Stefano Cavalieri, Giancarlo Aldini, Giovanna Baron, Ester Orlandi, N. Facchinetti, Domenico Attilio Romanello, & Laura D. Locati. (2021). A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia. Cancers, 13(3456).

Chicago

Paolo Bossi, Cristiana Bergamini, M. Franceschini, Nicola Alessandro Iacovelli, Rossana Ingargiola, Salvatore Alfieri, Stefano Cavalieri, et al. 2021. “A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.” Cancers 13 (3456). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1f9457212ff201b95cbbabb52a8e06ae&authtype=sso&custid=ns315887.